<DOC>
	<DOCNO>NCT00108082</DOCNO>
	<brief_summary>This study design compare effect COREG MR ( carvedilol modify release formulation ) atenolol index leave ventricular dimension add standardized angiotensin convert enzyme ( ACE ) inhibition , effect ACE inhibition alone . Subjects LVH ( leave ventricular hypertrophy ) hypertension study . The primary endpoint change leave ventricular mass index ( LVMI ) characterize magnetic resonance imaging ( MRI ) follow 12 month treatment . Secondary endpoint include change LV ( leave ventricular ) mass , LV wall thickness , diastolic leave ventricular filling parameter , leave ventricular ejection fraction echocardiographic method Treatment Month 12 . Composite outcome individual event data also evaluate treatment group .</brief_summary>
	<brief_title>The CLEVER Study - Coreg And Left Ventricular Mass Regression</brief_title>
	<detailed_description>A Randomized , Double-Blind , Multi-Center Study Comparing Effects Carvedilol Modified Release Formulation ( COREG MR ) Atenolol Combination Compared Angiotensin Converting Enzyme Inhibitor ( Lisinopril ) Left Ventricular Mass Regression Hypertensive Patients Left Ventricular Hypertrophy ( LVH ) .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>Inclusion criterion : Stage 1 Stage 2 hypertension . Left ventricular hypertrophy . Exclusion criterion : In atrial fibrillation . Takes betablocker MI ( myocardial infarction ) arrhythmia . Has uncontrolled diabetes , uncontrollable symptomatic arrhythmia , unstable angina , second third degree heart block , history MI , COPD ( chronic obstructive pulmonary disease ) , liver kidney disease . Uses beta2agonists . Unable undergo MRI ( magnetic resonance imaging ) . Females childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>leave ventricular hypertrophy ( LVH )</keyword>
	<keyword>echocardiogram</keyword>
	<keyword>leave ventricular mass regression</keyword>
	<keyword>cardiac MRI</keyword>
	<keyword>leave ventricular mass index ( LVMI ) hypertension</keyword>
</DOC>